Immuneering Corporation (IMRX) Tops Q1 EPS by 5c

Immuneering Corporation (NASDAQ: IMRX) reported Q1 EPS of ($0.44), $0.05 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Immuneering Corporation (IMRX) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Increasing unusual option volume: BLZE ADTN XYL BZFD DOMO IAG ARQQ PRIM USAS IVV ALLT RPD